Is this you? Create Your Porfile
Avatar

Gerhard Seemann

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Gerhard Seemann is active.

Explore More

Publication

Featured researches published by Gerhard Seemann.

Archive | 1990

Bispecific and oligospecific, mono- and oligovalent receptors, production and applications thereof

Klaus Bosslet; Peter Hermentin; Gerhard Seemann; Ludwig Kuhlmann; Axel Steinstrasser

Archive | 1990

Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof

Klaus Bosslet; Peter Hermentin; Gerhard Seemann; Ludwig Kuhlmann; Axel Steinstr asser

Archive | 1994

Tetravalent bispecific receptors, the preparation and use thereof

Klaus Bosslet; Gerhard Seemann

Archive | 1992

Glycosylated prodrugs, their method of preparation and their uses

Jean-Claude Jacquesy; Jean-Pierre Gesson; Claude Monneret; Martine Mondon; Brigitte Renoux; Jean-Claude Florent; Michel Koch; Fran Cedilla Ois Tillequin; Hans Harald Sedlacek; Manfred Gerken; Cenek Kolar; Klaus Bosslet; Org J. Czech; Dieter Hoffman; Gerhard Seemann; Hans-Ulrich Schorlemmer; Gerhard Dickneite

Archive | 1989

Antigens composed of "major histocompatibility complex" class I antigens and specific carrier molecules, their production and use

Gerhard Seemann; Klaus Bosslet; Hans Harald Sedlacek

Archive | 1993

Fusion proteins for prodrug activation

Mathias Gehrmann; Gerhard Seemann; Klaus Bosslet; Joerg Czech

Archive | 1992

Tetravalent bispecific receptors, their preparation and use

Klaus Bosslet; Gerhard Seemann

Archive | 1992

Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof

Gerhard Seemann; Klaus Bosslet; Joerg Czech; Cenek Kolar; Dieter Hoffmann; Hans-Harald Sedlacek

Archive | 2002

Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates

Cenek Kolar; Jörg Czech; Klaus Bosslet; Gerhard Seemann; Hans-Harald Sedlacek; Dieter Hoffman

Archive | 1990

Monoclonal antibodies against tumor associated antigen, their preparation and use

Klaus Bosslet; Gerhard Seemann; Hans-Harald Sedlacek; Bernhard Auerbach

Explore More

Collaboration

Dive into the Gerhard Seemann's collaboration.

Top Co-Authors
Avatar

Klaus Bosslet

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Joerg Czech

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Cenek Kolar

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Hans-Harald Sedlacek

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Peter Hermentin

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Dieter Hoffmann

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Hans Harald Sedlacek

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Manfred Gerken

University of Hamburg

View shared research outputs
Top Co-Authors
Avatar

Jörg Czech

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Bernhard Auerbach

Aventis Pharma

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge